CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 5)

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 40(Granted Patents)

Location History:

Berghem, NL (2003 - 2007)
BH Oss, NL (2008)
Borghem, NL (2009)
Oss, NL (2008 - 2018)

Company Filing History:

Merck Sharp + Dohme B.v.

Years Active: 2003-2018

Loading Chart...

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10155259 - FSH receptor antagonists (2018-12-18),

2. 9174940 - TSH receptor antagonizing tetrahydroquinoline compounds (2015-11-03),

3. 9127007 - FSH receptor antagonists (2015-09-08),

4. 9044463 - FSH receptor antagonists (2015-06-02),

5. 8431564 - Ring-annulated dihydropyrrolo[2,1-α]isoquinolines (2013-04-30),

6. 8394789 - (Dihydro)pyrrolo[2,1-α]isoquinolines (2013-03-12),

7. 8071589 - Dihydrobenzoindazoles (2011-12-06),

8. 8034945 - 4-phenyl-5-OXO-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility (2011-10-11),

9. 8022218 - 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives for the treatment of infertility (2011-09-20),

10. 8017782 - 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility (2011-09-13),

11. 7858794 - Tetrahydroquinoline derivatives (2010-12-28),

12. 7674909 - Tetrahydroquinoline derivatives and their use as FSH receptor modulators (2010-03-09),

13. 7618963 - Bicyclic heteroaromatic compounds (2009-11-17),

14. 7375109 - Glycine-substituted thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity (2008-05-20),

15. 7317006 - [object Object] (2008-01-08),

Title: **The Innovative Mind of Cornelis Marius Timmers**

Introduction

Cornelis Marius Timmers, an esteemed inventor based in Oss, Netherlands, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 18 patents. His inventive work focuses primarily on medical applications and therapeutic compounds that address various health issues.

Latest Patents

Among his latest advancements are two notable patents: the **FSH receptor antagonists** and the **TSH receptor antagonizing tetrahydroquinoline compounds**. The FSH receptor antagonist invention relates to compounds that either conform to a general formula or exist as pharmaceutically acceptable salts. These compounds have been designed for a range of applications, including the treatment and prevention of endometriosis, hormone-dependent breast cancer, contraception, and other menstrual-related disorders. Meanwhile, his TSH receptor antagonizing tetrahydroquinoline compounds aim to treat or prevent disorders linked to TSH receptor-mediated pathways such as hyperthyroidism, Graves' disease, and thyroid cancer, showcasing his commitment to advancing therapeutic solutions.

Career Highlights

Throughout his career, Timmers has collaborated with prominent companies in the pharmaceutical industry, including N.V. Organon and Merck Sharp & Dohme B.V. His experience in these organizations has not only sharpened his expertise but also enabled him to bring to fruition various innovative ideas that contribute to medical science.

Collaborations

Collaboration has played a crucial role in Timmers’ journey as an inventor. He has worked alongside notable professionals such as Willem Frederik Johan Karstens, which has fortified his innovative endeavors and fostered the development of impactful therapeutic technologies.

Conclusion

Cornelis Marius Timmers exemplifies the spirit of innovation in the pharmaceutical sector. His array of patents and collaborations underscores his ability to translate complex scientific concepts into practical applications that hold significant promise for improving health outcomes. As research and innovation continue to evolve, Timmers stands as a pillar of creativity and dedication in the realm of medical inventions.

This text is generated by artificial intelligence and may not be accurate.